Lars L Gustafsson

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF GERONTOLOGICAL SOCIAL WORK. 2024;67(6):841-860
Proud but Powerless: A Qualitative Study of Homecare Workers Work Experiences and Their Suggestions for How Care for Homebound Older Adults Can Be Improved
Bergqvist M; Bastholm-Rahmner P; Modig K; Gustafsson LL; Schmidt-Mende K
Article: BMC GERIATRICS. 2024;24(1):350
Homecare workers - an untapped resource in preventing emergency department visits among older individuals? A qualitative interview study from Sweden
Bastholm-Rahmner P; Bergqvist M; Modig K; Gustafsson LL; Schmidt-Mende K
Article: BMC GERIATRICS. 2024;24(1):312
Profiling chronic diseases and hospitalizations in older home care recipients: a nationwide cohort study in Sweden
Schmidt-Mende K; Arvinge C; Cioffi G; Gustafsson LL; Modig K; Meyer AC
Article: INTERNATIONAL JOURNAL OF OLDER PEOPLE NURSING. 2023;18(1):e12498
How much are we worth? Experiences of nursing assistants in Swedish nursing homes during the first wave of COVID-19
Bergqvist M; Bastholm-Rahmner P; Gustafsson LL; Holmgren K; Veg A; Wachtler C; Schmidt-Mende K
Article: LAKARTIDNINGEN. 2022;119:22079
[Pharmacological knowledge bases in Sweden: successes and future in a time of information overflow].
Gustafsson L; Eiermann B; Hoffmann M
Article: BJGP OPEN. 2022;6(2):BJGPO.2021.0181
Experiences of patients receiving Home Care and living with polypharmacy: a qualitative interview study
Mannheimer S; Bergqvist M; Bastholm-Rahmner P; Gustafsson LL; Veg A; Schmidt-Mende K
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2021;77(9):1323-1331
Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low
Heinonen E; Blennow M; Blomdahl-Wetterholm M; Hovstadius M; Nasiell J; Pohanka A; Gustafsson LL; Wide K
Article: EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH. 2021;21(4):527-540
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications
Godman B; Hill A; Simoens S; Selke G; Selke Krulichova I; Zampirolli Dias C; Martin AP; Oortwijn W; Timoney A; Gustafsson LL; Voncina L; Kwon H-Y; Gulbinovic J; Gotham D; Wale J; Da Silva WC; Bochenek T; Allocati E; Kurdi A; Ogunleye OO; Meyer JC; Hoxha I; Malaj A; Hierlander C; Sauermann R; Hamelinck W; Petrova G; Laius O; Langner I; Yfantopoulos J; Joppi R; Jakupi A; Greiciute-Kuprijanov I; Vella Bonanno P; Piepenbrink JH; de Valk V; Wladysiuk M; Markovic-Pekovic V; Mardare I; Furst J; Tomek D; Obach Cortadellas M; Zara C; Pontes C; McTaggart S; Laba T-L; Melien O; Wong-Rieger D; Bae S; Hill R
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2020;109(12):2706-2716
Pretreatment HIV drug resistance predicts accumulation of new mutations in ART-naive Ugandan children
Soeria-Atmadja S; Amuge P; Nanzigu S; Bbuye D; Rubin J; Eriksen J; Kekitiinwa A; Obua C; Gustafsson LL; Naver L
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2020;109(12):2789-2798
Parents' perspectives on dried blood spot self-sampling from children with epilepsy: A mixed-method study
Linder C; Neideman M; Gambell-Barroso M; Gustafsson LL; Wide K; Pohanka A; Bastholm-Rahmner P
Article: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2020;13(9):925-934
Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet
Hoffmann M; Vander Stichele R; Bates DW; Bjorklund J; Alexander S; Andersson ML; Auraaen A; Bennie M; Dahl M-L; Eiermann B; Hackl W; Hammar T; Hjemdahl P; Koch S; Kunnamo I; Le Louet H; Panagiotis P; Raego L; Spedding M; Seidling HM; Demner-Fushman D; Gustafsson LL
Article: THERAPEUTIC DRUG MONITORING. 2019;41(4):509-518
Dried Blood Spot Self-Sampling by Guardians of Children With Epilepsy Is Feasible: Comparison With Plasma for Multiple Antiepileptic Drugs
Linder C; Neideman M; Wide K; von Euler M; Gustafsson LL; Pohanka A
Article: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2019;12(5):481-489
Reported needs of information resources, research tools, connectivity and infrastructure among African Pharmacological Scientists to improve future patient care and health
Ogunleye OO; Fadare JO; Eriksen J; Oaiya O; Massele A; Truter I; Taylor SJE; Godman B; Gustafsson LL
Article: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2018;11(12):1255-1262
Drug and therapeutics committees in Nigeria: evaluation of scope and functionality
Fadare JO; Ogunleye O; Obiako R; Orubu S; Enwere O; Ajemigbitse AA; Meyer JC; Enato E; Massele A; Godman B; Gustafsson LL
Article: BMJ OPEN. 2018;8(8):e023281
MAGDALENA: study protocol of a randomised, placebo-controlled trial on cognitive development at 2 years of age in children exposed to SSRI in utero
Heinonen E; Szymanska-von Schultz B; Kaldo V; Nasiell J; Andersson E; Bergmark M; Blomdahl-Wetterholm M; Forsberg L; Forsell E; Forsgren A; Froojd S; Goldman A; Nordenadler E-M; Sklivanioti M; Blennow M; Wide K; Gustafsson LL
Article: ANESTHESIOLOGY. 2018;129(2):260-270
Combined Recirculatory-compartmental Population Pharmacokinetic Modeling of Arterial and Venous Plasma S(+) and R(-) Ketamine Concentrations
Henthorn TK; Avram MJ; Dahan A; Gustafsson LL; Persson J; Krejcie TC; Olofsen E
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2018;107(8):1379-1388
Maternal mood disorders and lithium exposure in utero were not associated with poor cognitive development during childhood
Forsberg I; Adler M; Ek IR; Ljungdahl M; Naver L; Gustafsson LL; Berglund G; Chotigasatien A; Hammar U; Bohm B; Wide K
Article: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2018;122(4):402-412
Policy Change and the National Essential Medicines List Development Process in Brazil between 2000 and 2014: Has the Essential Medicine Concept been Abandoned?
Osorio-de-Castro CGS; Azeredo TB; Pepe VLE; Lopes LC; Yamauti S; Godman B; Gustafsson LL
Article: BMC HEALTH SERVICES RESEARCH. 2018;18(1):176
Patients' knowledge and attitudes to the Wise List - a drug formulary from the Stockholm Drug and Therapeutic committee
Bastholm-Rahmner P; Gustafsson LL; Aggefors K; Ateva K; Elfving S; Eriksen J; Jirlow M; Juhasz-Haverinen M; Malmstrom RE; Nikpour-Ardaly M; Rojvall M; Vallin M; Andersen-Karlsson E; Ovesjo M-L
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2018;74(1):131-138
Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee's list of recommended essential medicines (the 'Wise List')
Eriksen J; Ovesjo M-L; Vallin M; Juhasz-Haverinen M; Andersen-Karlsson E; Ateva K; Gustafsson LL; Jirlow M; Bastholm-Rahmner P
Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2018;1072:116-122
Carbamazepine, lamotrigine, levetiracetam and valproic acid in dried blood spots with liquid chromatography tandem mass spectrometry; method development and validation
Linder C; Hansson A; Sadek S; Gustafsson LL; Pohanka A
Article: CLINICAL BIOCHEMISTRY. 2017;50(7-8):418-424
Comparison between dried blood spot and plasma sampling for therapeutic drug monitoring of antiepileptic drugs in children with epilepsy: A step towards home sampling
Linder C; Wide K; Walander M; Beck O; Gustafsson LL; Pohanka A
Article: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2017;120(5):457-465
Oil-Fortified Maize Porridge Increases Absorption of Lumefantrine in Children with Uncomplicated Falciparum Malaria
Mwebaza N; Jerling M; Gustafsson LL; Silva AV; Pohanka A; Obua C; Waako P; Beck O; Homann MV; Farnert A; Hellgren U
Article: CLINICAL INFECTIOUS DISEASES. 2017;64(2):199-206
High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series
Sonden K; Wyss K; Jovel I; da Silva AV; Pohanka A; Asghar M; Homann MV; Gustafsson LL; Hellgren U; Farnert A
Article: ONLINE JOURNAL OF PUBLIC HEALTH INFORMATICS. 2017;9(2):e188
Opportunities and obstacles using a clinical decision support system for maternal care in Burkina Faso.
Zakane SA; Gustafsson LL; Sie A; Tomson G; Loukanova S; Bastholm-Rahmner P
Article: PLOS ONE. 2017;12(9):e0181316
Genetic variants in CYP2B6 and CYP2A6 explain interindividual variation in efavirenz plasma concentrations of HIV-infected children with diverse ethnic origin
Soeria-Atmadja S; Osterberg E; Gustafsson LL; Dahl M-L; Eriksen J; Rubin J; Naver L
Article: GLOBAL HEALTH ACTION. 2017;10(1):1348693
Rebuilding research capacity in fragile states: the case of a Somali-Swedish global health initiative
Dalmar AA; Hussein AS; Walhad SA; Ibrahim AO; Abdi AA; Ali MK; Ereg DI; Egal KA; Shirwa AM; Aden MH; Yusuf MW; Abdi YA; Freij L; Johansson A; Mohamud KB; Abdulkadir Y; Emmelin M; Eriksen J; Erlandsson K; Gustafsson LL; Ivarsson A; Klingberg-Allvin M; Kinsman J; Kallestal C; Malqvist M; Osman F; Persson L-A; Sahlen K-G; Wall S
Article: LAKARTIDNINGEN. 2016;113:D93D
[Steps towards rational introduction of new pharmaceuticals in Sweden].
Gustafsson L
Article: PHARMACOGENOMICS. 2016;17(6):603-613
CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population
Mukonzo JK; Bisaso RK; Ogwal-Okeng J; Gustafsson LL; Owen JS; Aklillu E
Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2015;1004:60-66
A fast and sensitive method for quantifying lumefantrine and desbutyl-lumefantrine using LC-MS/MS
Silva AV; Mwebaza N; Ntale M; Gustafsson LL; Pohanka A
Article: BMJ OPEN. 2015;5(7):e006775
Development of a computerised decisions support system for renal risk drugs targeting primary healthcare
Hellden A; Al-Aieshy F; Bastholm-Rahmner P; Bergman U; Gustafsson LL; Hook H; Sjoviker S; Soderstrom A; Odar-Cederlof I
Article: LAKARTIDNINGEN. 2015;112:DD9Y
[Healthcare IT systems and doctors' influence].
Gustafsson LL
Article: EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. 2015;13(2):279-289
The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications
Fuerst J; Cizman M; Mrak J; Kos D; Campbell S; Coenen S; Gustafsson LL; Fuerst L; Godman B
Article: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2015;116(2):146-157
Quality Indicators as a Tool in Improving the Introduction of New Medicines
Campbell SM; Godman B; Diogene E; Fuerst J; Gustafsson LL; MacBride-Stewart S; Malmstrom RE; Pedersen H; Selke G; Vlahovic-Palcevski V; van Woerkom M; Wong-Rieger D; Wettermark B
Article: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2015;8(1):77-94
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
Godman B; Malmstrom RE; Diogene E; Gray A; Jayathissa S; Timoney A; Acurcio F; Alkan A; Brzezinska A; Bucsics A; Campbell SM; Czeczot J; de Bruyn W; Eriksson I; Yusof FAM; Finlayson AE; Furst J; Garuoliene K; Guerra Junior A; Gulbinovic J; Jan S; Joppi R; Kalaba M; Magnisson E; McCullagh L; Miikkulainen K; Ofierska-Sujkowska G; Pedersen HB; Selke G; Sermet C; Spillane S; Supian A; Truter I; Vlahovic-Palcevski V; Vien LE; Vural EH; Wale J; Wladysiuk M; Zeng W; Gustafsson LL
Article: EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH. 2015;15(1):157-169
Review of ongoing initiatives to improve prescribing efficiency in China; angiotensin receptor blockers as a case history
Zeng W; Gustafsson LL; Bennie M; Finlayson AE; Godman B
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2014;12(12):1986-1992
Selective serotonin reuptake inhibitor use during pregnancy increases the risk of postpartum hemorrhage and anemia: a hospital-based cohort study
Lindqvist PG; Nasiell J; Gustafsson LL; Nordstrom L
Article: LAKARTIDNINGEN. 2014;111(43):1894-1897
[Electronic support in the medical record for drug dosage in renal failure].
Helldén A; Al-Aieshy F; Bastholm-Rahmner P; Bergman U; Gustafsson LL; Sjöviker S; Söderström A; Odar-Cederlöf I
Article: SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION. 2014;74(7):648-652
Quantification of valproic acid in dried blood spots
Pohanka A; Mahindi M; Masquelier M; Gustafsson LL; Beck O
Article: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2014;115(3):268-276
An Analytical Framework for Assessing Drug and Therapeutics Committee Structure and Work Processes in Tertiary Brazilian Hospitals
Lima-Dellamora EDC; Caetano R; Gustafsson LL; Godman BB; Patterson K; Serpa Osorio-de-Castro CG
Article: BMC MEDICAL INFORMATICS AND DECISION MAKING. 2014;14:78
A cross-sectional pilot study assessing needs and attitudes to implementation of Information and Communication Technology for rational use of medicines among healthcare staff in rural Tanzania
Nilseng J; Gustafsson LL; Nungu A; Bastholm-Rahmner P; Mazali D; Pehrson B; Eriksen J
Article: INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS. 2014;83(6):459-469
Guidelines for maternal and neonatal "point of care": Needs of and attitudes towards a computerized clinical decision support system in rural Burkina Faso
Zakane SA; Gustafsson LL; Tomson G; Loukanova S; Sie A; Nasiell J; Bastholm-Rahmner P
Article: MEDICINE, CONFLICT AND SURVIVAL. 2014;30(1):28-36
The most fragile state: healthcare in Somalia.
Ali AM; Handuleh J; Patel P; Whitwell S; Harris K; Ali FR; Southgate RJ; Godman B; Al-Hadithy N; Gustafsson LL; Finlayson AET
Article: ONLINE JOURNAL OF PUBLIC HEALTH INFORMATICS. 2014;6(2):e180
Perceived value of applying Information Communication Technology to implement guidelines in developing countries; an online questionnaire study among public health workers.
Machingura PI; Adekola O; Mueni E; Oaiya O; Gustafsson LL; Heller RF
Article: PLOS ONE. 2014;9(1):e86919
Pharmacogenetic-Based Efavirenz Dose Modification: Suggestions for an African Population and the Different CYP2B6 Genotypes
Mukonzo JK; Owen JS; Ogwal-Okeng J; Kuteesa RB; Nanzigu S; Sewankambo N; Thabane L; Gustafsson LL; Ross C; Aklillu E
Article: PLOS ONE. 2014;9(11):e111327
Neonatal Adaptation in Infants Prenatally Exposed to Antidepressants-Clinical Monitoring Using Neonatal Abstinence Score
Forsberg L; Naver L; Gustafsson LL; Wide K
Article: GLOBAL HEALTH ACTION. 2014;7:24070
Nesting doctoral students in collaborative North-South partnerships for health systems research
Loukanova S; Prytherch H; Blank A; Duysburgh E; Tomson G; Gustafsson LL; Sie A; Williams J; Leshabari M; Haefeli WE; Sauerborn R; Fonn S
Article: APPLIED HEALTH ECONOMICS AND HEALTH POLICY. 2013;11(4):383-393
Changes in the utilization of venlafaxine after the introduction of generics in Sweden.
Godman B; Persson M; Miranda J; Skiöld P; Wettermark B; Barbui C; Gustafsson LL
Article: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2013;113(1):66-72
Comparable Lumefantrine Oral Bioavailability when Co-administered With Oil-Fortified Maize Porridge or Milk in Healthy Volunteers
Mwebaza N; Jerling M; Gustafsson LL; Obua C; Waako P; Mahindi M; Ntale M; Beck O; Hellgren U
Article: LAKARTIDNINGEN. 2013;110(25-26):1227
[Contradictory whether paracetamol is contraindicated after childhood vaccination].
Eriksen J; Gustafsson LL
Article: BMC INFECTIOUS DISEASES. 2013;13:261
Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study
Mukonzo JK; Okwera A; Nakasujja N; Luzze H; Sebuwufu D; Ogwal-Okeng J; Waako P; Gustafsson LL; Aklillu E
Article: APPLIED HEALTH ECONOMICS AND HEALTH POLICY. 2013;11(3):205-218
Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France.
Pichetti S; Sermet C; Godman B; Campbell SM; Gustafsson LL
Article: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2013;112(6):392-400
Extraction of Electronic Health Record Data in a Hospital Setting: Comparison of Automatic and Semi-Automatic Methods Using Anti-TNF Therapy as Model
Cars T; Wettermark B; Malmstrom RE; Ekeving G; Vikstrom B; Bergman U; Neovius M; Ringertz B; Gustafsson LL
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2013;69:73-78
Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations
Bjorkhem-Bergman L; Andersen-Karlsson E; Laing R; Diogene E; Melien O; Jirlow M; Malmstrom RE; Vogler S; Godman B; Gustafsson LL
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2013;69:65-72
The continuing challenge of providing drug information services to diminish the knowledge-practice gap in medical practice
Alvan G; Andersson ML; Asplund AB; Bottiger Y; Elwin C-E; Gustafsson LL; Ohman B; Tornqvist E
Article: BMC MEDICAL INFORMATICS AND DECISION MAKING. 2013;13:44
"Quality of prenatal and maternal care: bridging the know-do gap" (QUALMAT study): an electronic clinical decision support system for rural Sub-Saharan Africa
Blank A; Prytherch H; Kaltschmidt J; Krings A; Sukums F; Mensah N; Zakane A; Loukanova S; Gustafsson LL; Sauerborn R; Haefeli WE
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2013;69(4):889-899
Drugs and Birth Defects: a knowledge database providing risk assessments based on national health registers
Norby U; Kallen K; Eiermann B; Korkmaz S; Winbladh B; Gustafsson LL
Article: JOURNAL OF THE ROYAL SOCIETY OF MEDICINE. 2013;106(2):41-44
Personalizing healthcare: from genetics through payment to improving care?
Finlayson AE; Godman B; Paterson K; Aston E; Haycox A; Gustafsson LL; Ali R
Article: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2013;67(2):170-180
Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications
Bennie M; Bishop I; Godman B; Barbui C; Raschi E; Campbell S; Miranda J; Gustafsson LL
Article: AUDIT TRENDS. 2013;21(1):7-15
Are prescribing initiatives readily transferable across classes: the case of generic losartan in Scotland?
Bennie M; Bishop I; Godman B; Campbell S; Miranda J; Finlayson AE; Gustafsson LL
Article: FRONTIERS IN PHARMACOLOGY. 2013;4:39
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs
Malmstrom RE; Godman BB; Diogene E; Baumgartel C; Bennie M; Bishop I; Brzezinska A; Bucsics A; Campbell S; Ferrario A; Finlayson AE; Furst J; Garuoliene K; Gomes M; Gutierrez-Ibarluzea I; Haycox A; Hviding K; Herholz H; Hoffmann M; Jan S; Jones J; Joppi R; Kalaba M; Kvalheim C; Laius O; Langner I; Lonsdale J; Loov S-A; Malinowska K; McCullagh L; Paterson K; Markovic-Pekovic V; Martin A; Piessnegger J; Selke G; Sermet C; Simoens S; Tulunay C; Tomek D; Voncina L; Vlahovic-Palcevski V; Wale J; Wilcock M; Wladysiuk M; van Woerkom M; Zara C; Gustafsson LL
Article: JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH. 2012;1(6):527-538
Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications
van Woerkom M; Piepenbrink H; Godman B; de Metz J; Campbell S; Bennie M; Eimers M; Gustafsson LL
Article: EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH. 2012;12(5):661-671
Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions
Markovic-Pekovic V; Skrbic R; Godman B; Gustafsson LL
Article: LAKARTIDNINGEN. 2012;109(32-33):1398-1399
[Medical and academic leadership is required for IT support for drugs. The principles of good decision support practice (GDSP) should be followed].
Gustafsson LL
Article: IMPLEMENTATION SCIENCE. 2012;7:31
'How to know what you need to do': a cross-country comparison of maternal health guidelines in Burkina Faso, Ghana and Tanzania
Baker U; Tomson G; Some M; Kouyate B; Williams J; Mpembeni R; Massawe S; Blank A; Gustafsson LL; Eriksen J
Article: HIV MEDICINE. 2012;13(4):193-201
Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected Ugandans
Nanzigu S; Eriksen J; Makumbi F; Lanke S; Mahindi M; Kiguba R; Beck O; Ma Q; Morse GD; Gustafsson LL; Waako P
Article: EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH. 2012;12(1):115-124
Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi
Abuelkhair M; Abdu S; Godman B; Fahmy S; Malmstrom RE; Gustafsson LL
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2012;73(1):115-125
Physicians' reported needs of drug information at point of care in Sweden
Rahmner PB; Eiermann B; Korkmaz S; Gustafsson LL; Gruven M; Maxwell S; Eichle H-G; Veg A
Article: FRONTIERS IN PHARMACOLOGY. 2012;3:198
Potential to enhance the prescribing of generic drugs in patients with mental health problems in Austria; implications for the future
Godman B; Bucsics A; Burkhardt T; Piessnegger J; Schmitzer M; Barbui C; Raschi E; Bennie M; Gustafsson LL
Article: TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE. 2012;106(1):3-9
Adherence to artemether/lumefantrine treatment in children under real-life situations in rural Tanzania
Simba DO; Kakoko D; Tomson G; Premji Z; Petzold M; Mahindi M; Gustafsson LL
Article: LAKARTIDNINGEN. 2011;108(50):2662
[Red yeast rice can lower cholesterol but should not replace established therapy].
Gustafsson LL
Article: AFRICAN HEALTH SCIENCES. 2011;11(3):493-498
Use of a pilot drug information centre
Tumwikirize AW; Ogwal-Okeng JW; Vernby A; Anokbonggo WW; Gustafsson LL; Lundborg CS
Article: CLINICAL PHARMACOKINETICS. 2011;50(8):531-540
HIV/AIDS Patients Display Lower Relative Bioavailability of Efavirenz than Healthy Subjects
Mukonzo JK; Nanzigu S; Rekic D; Waako P; Roshammar D; Ashton M; Ogwal-Okeng J; Gustafsson LL; Aklillu E
Article: EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH. 2011;11(4):469-479
Influence of demand-side measures to enhance renin-angiotensin prescribing efficiency in Europe: implications for the future
Voncina L; Strizrep T; Godman B; Bennie M; Bishop I; Campbell S; Vlahovic-Palcevski V; Gustafsson LL
Article: NATURE REVIEWS DRUG DISCOVERY. 2011;10(7):495-506
Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response
Eichler H-G; Abadie E; Breckenridge A; Flamion B; Gustafsson LL; Leufkens H; Rowland M; Schneider CK; Bloechl-Daum B
Article: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2011;108(4):224-233
The 'Wise List' - A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm
Gustafsson LL; Wettermark B; Godman B; Andersen-Karlsson E; Bergman U; Hasselstrom J; Hensjo L-O; Hjemdahl P; Jagre I; Julander M; Ringertz B; Schmidt D; Sjoberg S; Sjoqvist F; Stiller C-O; Tornqvist E; Tryselius R; Vitols S; von Bahr C
Article: AFRICAN HEALTH SCIENCES. 2011;11(1):72-78
Adverse drug reactions in patients admitted on Internal Medicine wards in a district and Regional Hospital in Uganda
Tumwikirize WA; Ogwal-Okeng JW; Vernby A; Anokbonggo WW; Gustafsson LL; Lundborg SC
Article: LABORATORY MEDICINE. 2011;42(2):94-101
CD4-T-Lymphocyte Reference Ranges in Uganda and Its Influencing Factors
Nanzigu S; Waako P; Petzold M; Kiwanuka G; Dungu H; Makumbi F; Gustafsson LL; Eriksen J
Article: PLOS ONE. 2011;6(7):e19753
Malaria Rapid Testing by Community Health Workers Is Effective and Safe for Targeting Malaria Treatment: Randomised Cross-Over Trial in Tanzania
Mubi M; Janson A; Warsame M; Martensson A; Kallander K; Petzold MG; Ngasala B; Maganga G; Gustafsson LL; Massele A; Tomson G; Premji Z; Bjorkman A
Article: THERAPEUTICS AND CLINICAL RISK MANAGEMENT. 2011;7:441-446
Correlation between lamivudine plasma concentrations and patient self-reported adherence to antiretroviral treatment in experienced HIV patients
Minzi OM; Mugoyela V; Gustafsson LL
Article: AFRICAN HEALTH SCIENCES. 2010;10(4):332-340
Effectiveness of a community intervention on malaria in rural Tanzania - a randomised controlled trial
Eriksen J; Mujinja P; Warsame M; Nsimba S; Kouyate B; Gustafsson LL; Jahn A; Mueller O; Sauerborn R; Tomson G
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2010;66(12):1229-1234
Effects of Plasmodium falciparum infection on the pharmacokinetics of quinine and its metabolites in pregnant and non-pregnant Sudanese women
Mirghani RA; Elagib I; Elghazali G; Hellgren U; Gustafsson LL
Article: BMC HEALTH SERVICES RESEARCH. 2010;10:153
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
Adamski J; Godman B; Ofierska-Sujkowska G; Osinska B; Herholz H; Wendykowska K; Laius O; Jan S; Sermet C; Zara C; Kalaba M; Gustafsson R; Garuoliene K; Haycox A; Garattini S; Gustafsson LL
Article: THERAPEUTIC DRUG MONITORING. 2010;32(3):346-352
Genetic Variations in ABCB1 and CYP3A5 as well as Sex Influence Quinine Disposition Among Ugandans
Mukonzo JK; Waako P; Ogwal-Okeng J; Gustafsson LL; Aklillu E
Article: BMC HEALTH SERVICES RESEARCH. 2010;10:128
Forecasting drug utilization and expenditure in a metropolitan health region
Wettermark B; Persson ME; Wilking N; Kalin M; Korkmaz S; Hjemdahl P; Godman B; Petzold M; Gustafsson LL
Article: LAKARTIDNINGEN. 2010;107(3):102-105
[Efficient and safe drug therapy requires better IT systems. A survey among the chairmen of the Swedish Drug and Therapeutics Committees reveals shortages].
Lexne E; Johansson EK; Petersson G; Gustafsson LL
Article: FRONTIERS IN PHARMACOLOGY. 2010;1:141
Policies to enhance prescribing efficiency in Europe: findings and future implications
Godman B; Shrank W; Andersen M; Berg C; Bishop I; Burkhardt T; Garuoliene K; Herholz H; Joppi R; Kalaba M; Laius O; Lonsdale J; Malmstrom RE; Martikainen JE; Samaluk V; Sermet C; Schwabe U; Teixeira I; Tilson L; Tulunay FC; Vlahovic-Palcevski V; Wendykowska K; Wettermark B; Zara C; Gustafsson LL
Article: ANNALS OF FAMILY MEDICINE. 2010;8(1):40-46
Whose Job Is It Anyway? Swedish General Practitioners' Perception of Their Responsibility for the Patient's Drug List
Rahmner PB; Gustafsson LL; Holmstrom I; Rosenqvist U; Tomson G
Article: HEALTH INFORMATICS JOURNAL. 2009;15(4):305-319
Data extraction from a semi-structured electronic medical record system for outpatients: A model to facilitate the access and use of data for quality control and research
Kristianson KJ; Ljunggren H; Gustafsson LL
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2009;68(5):690-699
A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans
Mukonzo JK; Roshammar D; Waako P; Andersson M; Fukasawa T; Milani L; Svensson JO; Ogwal-Okeng J; Gustafsson LL; Aklillu E
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2009;65(6):627-633
SFINX-a drug-drug interaction database designed for clinical decision support systems
Bottiger Y; Laine K; Andersson ML; Korhonen T; Molin B; Ovesjo M-L; Tirkkonen T; Rane A; Gustafsson LL; Eiermann B
Article: FAMILY PRACTICE. 2009;26(2):121-127
Variations in understanding the drug-prescribing process: a qualitative study among Swedish GPs
Rahmner PB; Gustafsson LL; Larsson J; Rosenqvist U; Tomson G; Holmstrom I
Article: MALARIA JOURNAL. 2009;8:52
Field-adapted sampling of whole blood to determine the levels of amodiaquine and its metabolite in children with uncomplicated malaria treated with amodiaquine plus artesunate combination
Ntale M; Obua C; Mukonzo J; Mahindi M; Gustafsson LL; Beck O; Ogwal-Okeng JW
Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2008;876(2):261-265
A field-adapted sampling and HPLC quantification method for lumefantrine and its desbutyl metabolite in whole blood spotted on filter paper
Ntale M; Ogwal-Okeng JW; Mahindi M; Gustafsson LL; Beck O
Article: AFRICAN HEALTH SCIENCES. 2008;8(4):220-226
Access and use of medicines information sources by physicians in public hospitals in Uganda: a cross-sectional survey
Tumwikirize WA; Ogwal-Okeng JW; Vernby A; Anokbonggo WW; Gustafsson LL; Lundborg CS
Article: LAKARTIDNINGEN. 2008;105(45):3177-3178
[Following a Lex Maria case: safe computer support systems for drug prescription required].
Shemeikka T; Gustafsson LL; Korkmaz S
Article: LAKARTIDNINGEN. 2008;105(42):2917-2922
[A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment].
Gustafsson LL; Wettermark B; Kalin M; Korkmaz S; Persson ME; Almkvist H; Hjemdahl P; Julander M; Kristianson K; Ringertz B; Bergen-Dahl GT; Wilking N
Article: MALARIA JOURNAL. 2008;7:199
Impact of training in clinical and microscopy diagnosis of childhood malaria on antimalarial drug prescription and health outcome at primary health care level in Tanzania: A randomized controlled trial
Ngasala B; Mubi M; Warsame M; Petzold MG; Massele AY; Gustafsson LL; Tomson G; Premji Z; Bjorkman A
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2008;65(4):493-501
Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen
Obua C; Hellgren U; Ntale M; Gustafsson LL; Ogwal-Okeng JW; Gordi T; Jerling M
Article: MALARIA JOURNAL. 2008;7:50
Process and effects of a community intervention on malaria in rural Burkina Faso:: randomized controlled trial
Kouyate B; Some F; Jahn A; Coulibaly B; Eriksen J; Sauerborn R; Gustafsson L; Tomson G; Becher H; Mueller O
Article: PHARMACOGENETICS AND GENOMICS. 2008;18(3):201-208
4β-Hydroxycholesterol is a new endogenous CYP3A marker:: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians
Diczfalusy U; Miura J; Roh H-K; Mirghani RA; Sayi J; Larsson H; Bodin KG; Allqvist A; Jande M; Kim J-W; Aklillu E; Gustafsson LL; Bertilsson L
Article: TROPICAL MEDICINE AND INTERNATIONAL HEALTH. 2008;13(3):418-426
Clinical diagnosis of malaria and the risk of chloroquine self-medication in rural health centres in Burkina Faso
Pfeiffer K; Some F; Mueller O; Sie A; Kouyate B; Haefeli WE; Zoungrana A; Gustafsson LL; Tomson G; Sauerborn R
Article: TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE. 2008;102(2):137-142
Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania
Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustaftson LL; Warsame M
Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2007;859(1):137-140
A field-adapted HPLC method for determination of amodiaquine and its metabolite in whole blood dried on filter paper
Ntale M; Mahindi M; Ogwal-Okeng JW; Gustafsson LL; Beck O
Article: INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS. 2007;76(7):497-506
Design and implementation of a point-of-care computerized system for drug therapy in Stockholm metropolitan health region -: Bridging the gap between knowledge and practice
Sjoborg B; Backstrom T; Arvidsson L-B; Andersen-Karlsson E; Blomberg LB; Eiermann B; Eliasson M; Henriksson K; Jacobsson L; Jacobsson U; Julander M; Kaiser P-O; Landberg C; Larsson J; Molin B; Gustafsson LL
Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2007;81(5):708-712
CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavir
Josephson F; Allqvist A; Janabi M; Sayi J; Aklillu E; Jande M; Mahindi M; Burhenne J; Bottiger Y; Gustafsson LL; Haefeli WE; Bertilsson L
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2007;63(5):457-462
Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered
Minzi OMS; Gupta A; Haule AF; Kagashe GAB; Massele AY; Gustafsson LL
Article: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2007;32(1):15-19
Pharmacokinetics of quinine and its metabolites in pregnant Sudanese women with uncomplicated Plasmodium falciparum malaria
Abdelrahim II; Adam I; Elghazali G; Gustafsson LL; Elbashir MI; Mirghani RA
Article: TROPICAL MEDICINE AND INTERNATIONAL HEALTH. 2007;12(1):52-61
Assessing health worker performance in malaria case management of underfives at health facilities in a rural Tanzanian district
Eriksen J; Tomson G; Mujinja P; Warsame MY; Jahn A; Gustafsson LL
Article: ACTA TROPICA. 2006;100(1-2):142-150
Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: Experience with fixed-dose formulation
Obua C; Gustafsson LL; Aguttu C; Anokbonggo WW; Ogwal-Okeng JW; Chiria J; Hellgren U
Article: PHARMACOGENETICS AND GENOMICS. 2006;16(9):637-645
CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population
Mirghani RA; Sayi J; Aklillu E; Allqvist A; Jande M; Wennerholm A; Eriksen J; Herben VMM; Jones BC; Gustafsson LL; Bertilsson L
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2006;62(7):539-546
Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo
Wennerholm A; Nordmark A; Pihlsgard M; Mahindi M; Bertilsson L; Gustafsson LL
Article: AFRICAN HEALTH SCIENCES. 2006;6(2):86-92
Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda.
Obua C; Ntale M; Lundblad MS; Mahindi M; Gustafsson LL; Ogwal-Okeng JW; Anokbonggo WW; Hellgren U
Article: TROPICAL DOCTOR. 2006;36(2):93-97
Existence of antimalarial formulations with low bioavailability in Tanzania
Minzi OMS; Massele AY; Justin-Temu M; Ericsson Ö; Gustafsson LL
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2006;62(4):251-258
Janus computerised prescribing system provides pharmacological knowledge at point of care - design, development and proof of concept
Eliasson M; Bastholm P; Forsberg P; Henriksson K; Jacobson L; Nilsson A; Gustafsson LL
Article: PSYCHOPHARMACOLOGY. 2005;182(3):375-383
Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man
Aalto S; Ihalainen J; Hirvonen J; Kajander J; Scheinin H; Tanila H; Någren K; Vilkman H; Gustafsson LL; Syvälahti E; Hietala J
Article: TROPICAL MEDICINE AND INTERNATIONAL HEALTH. 2005;10(10):1038-1046
Adoption of the new antimalarial drug policy in Tanzania - a cross-sectional study in the community
Eriksen J; Nsimba SED; Minzi OMS; Sanga AJ; Petzold M; Gustafsson LL; Warsame MY; Tomson G
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2005;14(8):579-588
A study of adherence to drug recommendations by providing feedback of outpatient prescribing patterns to hospital specialists
Wettermark B; Haglund K; Gustafsson LL; Persson PM; Bergman U
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2005;61(2):113-118
Alprazolam as a probe for CYP3A using a single blood sample:: pharmacokinetics of parent drug, and of α- and 4-hydroxy metabolites in healthy subjects
Wennerholm A; Allqvist A; Svensson JO; Gustafsson LL; Mirghani RA; Bertilsson L
Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2005;814(1):179-183
Simple and cost-effective liquid chromatographic method for determination of pyrimethamine in whole blood samples dried on filter paper
Minzi OMS; Massele AY; Gustafsson LL; Ericsson Ö
Article: LEADERSHIP IN HEALTH SERVICES. 2004;17(4-5):173-179
Physicians' perceptions of possibilities and obstacles prior to implementing a computerised drug prescribing support system.
Bastholm Rahmner P; Andersén-Karlsson E; Arnhjort T; Eliasson M; Gustafsson LL; Jacobsson L; Ovesjö ML; Rosenqvist U; Sjöviker S; Tomson G; Holmström I
Article: TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE. 2004;98(6):347-353
Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment
Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
Article: LAKARTIDNINGEN. 2004;101(3):228-229
[Choice of antihypertensive agent--insignificant role of doxazosin (Alfadil). How are evidence-based recommendations implemented?].
Gustafsson LL
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2003;56(4):415-421
Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes
Herrlin K; Yasui-Furukori N; Tybring G; Widén J; Gustafsson LL; Bertilsson L
Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2003;795(1):151-156
High-performance liquid chromatographic method for the determination of quinine and 3-hydroxyquinine in blood samples dried on filter paper
Jansson Å; Gustafsson LL; Mirghani RA
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2003;59(5-6):429-442
Identification of human cytochrome P₄₅₀s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data
Li XQ; Björkman A; Andersson TB; Gustafsson LL; Masimirembwa CM
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2003;56(3):337-340
Interferon-β treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activity
Hellman K; Roos E; Österlund A; Wahlberg A; Gustafsson LL; Bertilsson L; Fredrikson S
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2003;59(5-6):423-427
Metabolism and elimination of quinine in healthy volunteers
Mirghani RA; Hellgren U; Bertilsson L; Gustafsson LL; Ericsson Ö
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2003;59(1):23-28
Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man
Mirghani RA; Ericsson Ö; Tybring G; Gustafsson LL; Bertilsson L
Article: LAKARTIDNINGEN. 2003;100(15):1338-1344
[Computerized decision support in drug prescribing II: A national database to provide up-to-date and unbiased information].
Gustafsson LL; Widäng K; Hoffmann M; Andersén-Karlsson E; Elfman K; Johansson B; Johansson E; Larson M
Article: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2003;28(2):117-122
Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania
Minzi OMS; Moshi MJ; Hipolite D; Massele AY; Tomson G; Ericsson Ö; Gustafsson LL
Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2003;783(2):473-480
High-performance liquid chromatographic method for determination of amodiaquine, chloroquine and their monodesethyl metabolites in biological samples
Minzi OMS; Rais M; Svensson JO; Gustafsson LL; Ericsson Ö
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2003;55(1):14-22
Rectal ropivacaine is absorbed proportionally to the dose, with low intraindividual variability
Arlander E; Sjövall J; Sörstad J; Norsten-Höög C; Gustafsson LL
Article: PSYCHOPHARMACOLOGY. 2002;164(4):401-406
Ketamine does not decrease striatal dopamine D₂ receptor binding in man
Aalto S; Hirvonen J; Kajander J; Scheinin H; Någren K; Vilkman H; Gustafsson L; Syvälahti E; Hietala J
Article: DRUG METABOLISM AND DISPOSITION. 2002;30(12):1368-1371
Enzyme kinetics for the formation of 3-hydroxyquinine and three new metabolites of quinine in vitro;: 3-hydroxylation by CYP3A4 is indeed the major metabolic pathway
Mirghani RA; Yasar Ü; Zheng T; Cook JM; Gustafsson LL; Tybring G; Ericsson Ö
Article: PHARMACOGENETICS AND GENOMICS. 2002;12(5):375-383
Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in Sweden
Aklillu E; Herrlin K; Gustafsson LL; Bertilsson L; Ingelman-Sundberg M
Article: TROPICAL MEDICINE AND INTERNATIONAL HEALTH. 2002;7(3):201-209
Case management of malaria in under-fives at primary health care facilities in a Tanzanian district
Nsimba SED; Massele AY; Eriksen J; Gustafsson LL; Tomson G; Warsame M
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2002;57(12):869-875
Pharmacokinetics and non-analgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity
Persson J; Hasselström J; Maurset A; Öye I; Svensson JO; Almqvist O; Scheinin H; Gustafsson LL; Almqvist O
Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2002;71(1):77-88
The African-specific CΥP2D6*17 allele encodes an enzyme with changed substrate specificity
Wennerholm A; Dandara C; Sayi J; Svensson JO; Abdi YA; Ingelman-Sundberg M; Bertilsson L; Hasler J; Gustafsson LL
Article: PHARMACOGENETICS AND GENOMICS. 2001;11(5):417-427
Characterization of the CYP2D6*29 allele commonly present in a blade Tanzanian population causing reduced catalytic activity
Wennerholm A; Johansson I; Hidestrand M; Bertilsson L; Gustafsson LL; Ingelman-Sundberg M
Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2001;754(1):57-64
Simultaneous determination of quinine and four metabolites in plasma and urine by high-performance liquid chromatography
Mirghani RA; Ericsson Ö; Cook J; Yu P; Gustafsson LL
Article: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2001;26(1):43-48
Comparative in vitro and in vivo study of a sugar-coated chloroquine preparation marketed in Tanzania versus an ordinary brand
Nsimba SED; Aden-Abdi Y; Rimoy G; Massele AY; Alm C; Ericsson O; Gustafsson LL
Article: THE LANCET. 2000;356(9247):2069-2070
Methadone, ciprofloxacin, and adverse drug reactions
Herrlin K; Segerdahl M; Gustafsson LL; Kalso E
Article: LAKARTIDNINGEN. 2000;97(39):4347
[Reply 1: LAKSAK supports wise drug therapy using knowledge and sharp IT-tools].
Gustafsson LL; Hensjö LO
Article: ACTA OTO-LARYNGOLOGICA. 2000;120(5):600-606
Changes in 2f₁-f₂ acoustic distortion products in humans during quinine-induced cochlear dysfunction
Berninger E; Gustafsson LL
Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2000;68(2):189-198
Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotype
Herrlin K; Massele AY; Rimoy G; Alm C; Rais M; Ericsson Ö; Bertilsson L; Gustafsson LL
Article: EUROPEAN JOURNAL OF ANAESTHESIOLOGY. 2000;17(3):197-203
Postoperative nausea and vomiting after breast surgery:: efficacy of prophylactic ondansetron and droperidol in a randomized placebo-controlled study
Reihnér E; Grunditz R; Giesecke K; Gustafsson LL
Article: PHARMACOGENETICS AND GENOMICS. 1999;9(6):707-714
Decreased capacity for debrisoquine metabolism among black Tanzanians:: analyses of the CYP2D6 genotype and phenotype
Wennerholm A; Johansson I; Massele AY; Jande M; Alm C; Aden-Abdi Y; Dahl ML; Ingelman-Sundberg M; Bertilsson L; Gustafsson LL
Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 1999;66(5):454-460
The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo
Mirghani RA; Hellgren U; Westerberg PA; Ericsson O; Bertilsson L; Gustafsson LL
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 1999;48(4):564-572
Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity
Brynne N; Forslund C; Hallén B; Gustafsson LL; Bertilsson L
Article: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 1999;43(7):744-752
Ketamine antagonises alfentanil-induced hypoventilation in healthy male volunteers
Persson J; Scheinin H; Hellström G; Björkman S; Götharson E; Gustafsson LL
Article: TROPICAL MEDICINE AND INTERNATIONAL HEALTH. 1998;3(11):913-917
Discrepancy in plasma melarsoprol concentrations between HPLC and bioassay methods in patients with T gambiense sleeping sickness indicates that melarsoprol is metabolized
Bronner U; Brun R; Doua F; Ericsson Ö; Burri C; Keiser J; Miézan TW; Boa YF; Rombo L; Gustafsson LL
Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 1998;64(5):484-491
Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4:: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors
Arlander E; Ekström G; Alm C; Carrillo JA; Bielenstein M; Böttiger Y; Bertilsson L; Gustafsson LL
Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 1998;64(4):391-401
Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype
Herrlin K; Massele AY; Jande M; Alm C; Tybring G; Abdi YA; Wennerholm A; Johansson I; Dahl ML; Bertilsson L; Gustafsson LL
Article: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 1998;42(7):750-758
The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans
Persson J; Hasselström J; Wiklund B; Heller A; Svensson JO; Gustafsson LL
Article: DRUG INFORMATION JOURNAL. 1998;32(3):777-785
Drug information sources: Reported preferences by general practitioners
Lundborg CS; Hensjo LO; Gustafsson LL
Article: BRITISH JOURNAL OF ANAESTHESIA. 1998;81(1):86-93
Adverse effects of extradural and intrathecal opiates: Report of a nationwide survey in Sweden
Gustafsson LL; Schildt B; Jacobsen K
Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 1998;708(1-2):209-216
High-performance liquid chromatographic method for the determination of the major quinine metabolite, 3-hydroxyquinine, in plasma and urine
Mirghani RA; Ericsson Ö; Gustafsson LL
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 1997;52(4):299-305
Chloroquine blood concentrations and malaria prophylaxis in Tanzanian women during the second and third trimesters of pregnancy
Massele AY; Kilewo C; Abdi YA; Tomson G; Diwan VK; Ericsson O; Rimoy G; Gustafsson LL
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 1997;52(3):167-172
''Academic drug-detailing'': From project to practice in a Swedish urban area
Lundborg CS; Hensjo LO; Gustafsson L
Article: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 1997;41(4):466-472
Preoperative infiltration of bupivacaine - Effects on pain relief and trauma response (cortisol and interleukin-6)
ErikssonMjoberg M; Kristiansson M; Carlstrom K; Eklund J; Gustafsson LL; Olund A
Article: THERAPEUTIC DRUG MONITORING. 1997;19(2):126-131
Intraindividual and interindividual variability in the disposition of the local anesthetic ropivacaine in healthy subjects
Emanuelsson BM; Persson J; Sandin S; Alm C; Gustafsson LL
Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 1997;690(1-2):243-251
Determination of melarsoprol in biological fluids by high-performance liquid chromatography and characterisation of two stereoisomers by nuclear magnetic resonance spectroscopy
Ericsson O; Schweda EKH; Bronner U; Rombo L; Friden M; Gustafsson LL
Article: BRITISH JOURNAL OF ANAESTHESIA. 1997;78(1):10-16
Extradural morphine gives better pain relief than patient-controlled iv morphine after hysterectomy
ErikssonMjoberg M; Svensson JO; Almkvist O; Olund A; Gustafsson LL
Article: JOURNAL OF INTERNAL MEDICINE. 1996;240(5):311-314
Cyclophosphamide-induced acute liver failure requiring transplantation in a patient with genetically deficient debrisoquine metabolism: A causal relationship?
Gustafsson LL; Eriksson LS; Dahl ML; Eleborg L; Ericzon BG; Nyberg A
Article: LAKARTIDNINGEN. 1996;93(20):1928-1930
[A new form for every fifth prescription!].
Bergman U; Gustafsson LL; Rydberg U
Article: JOURNAL OF CHROMATOGRAPHY. B, BIOMEDICAL APPLICATIONS. 1996;678(2):373-376
Determination of ketamine and norketamine enantiomers in plasma by solid-phase extraction and high-performance liquid chromatography
Svensson JO; Gustafsson LL
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 1996;41(4):344-346
Lack of effect of chloroquine on the debrisoquine (CYP2D6) and S-mephenytoin (CYP2C19) hydroxylation phenotypes
Masimirembwa CM; Gustafsson LL; Dahl ML; Abdi YA; Hasler JA
Article: ANESTHESIOLOGY. 1996;84(2):415-427
Quantitation of depth of thiopental anesthesia in the rat
Gustafsson LL; Ebling WF; Osaki E; Stanski DR
Article: TROPICAL MEDICINE AND INTERNATIONAL HEALTH. 1996;1(6):A37-A38
Determination of melarsoprol concentrations in plasma, urine and CSF in patients with human African trypanosomiasis using HPLC and bioassay.
Bronner U; Brun R; Burri C; Doua F; Ericsson O; Rombo L; Gustafsson LL
Article: TROPICAL MEDICINE AND INTERNATIONAL HEALTH. 1996;1(6):A32
Rational and simplified drug dosage regimens for therapy of parasitic diseases
Gustafsson L; Bronner U; Ericsson O
Article: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 1995;77(2):114-120
METABOLISM IS AN IMPORTANT ROUTE OF PENTAMIDINE ELIMINATION IN THE RAT - DISPOSITION OF C-14 PENTAMIDINE AND IDENTIFICATION OF METABOLITES IN URINE USING LIQUID CHROMATOGRAPHY-TANDEM MASS-SPECTROMETRY
BRONNER U; ERICSSON O; NORDIN J; WIKSTROM I; ABDI YA; HALL JE; TIDWELL RR; GUSTAFSSON LL
Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 1995;58(2):165-173
CENTRAL-NERVOUS-SYSTEM EFFECTS OF SUBDISSOCIATIVE DOSES OF (S)-KETAMINE ARE RELATED TO PLASMA AND BRAIN CONCENTRATIONS MEASURED WITH POSITRON EMISSION TOMOGRAPHY IN HEALTHY-VOLUNTEERS
HARTVIG P; VALTYSSON J; LINDNER KJ; KRISTENSEN J; KARLSTEN R; GUSTAFSSON LL; PERSSON J; SVENSSON JO; OYE I; ANTONI G; WESTERBERG G; LANGSTROM B
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 1995;39(3):289-295
PHARMACOKINETICS AND ADVERSE REACTIONS AFTER A SINGLE-DOSE OF PENTAMIDINE IN PATIENTS WITH TRYPANOSOMA GAMBIENSE SLEEPING SICKNESS
BRONNER U; GUSTAFSSON LL; DOUA F; ERICSSON O; MIEZAN T; RAIS M; ROMBO L
Article: LIFE SCIENCES. 1995;57(25):2335-2345
CEREBRAL UPTAKE OF MORPHINE IN THE PIG CALCULATED FROM ARTERIOVENOUS PLASMA-CONCENTRATION GRADIENTS - AN ALTERNATIVE TO TISSUE MICRODIALYSIS
BJORKMAN S; AKESON J; HELFER M; FYGE A; GUSTAFSSON LL
Visa fler

Alla övriga publikationer

Editorial comment: GLOBAL HEALTH ACTION. 2023;16(1):2290638
Strengthening Global Health Research
Gustafsson LL
Review: STUDIES IN HEALTH TECHNOLOGY AND INFORMATICS. 2022;294:450-454
An Adverse Drug Reaction Database for Clinical Use - Potential of and Difficulties with the Summary of Product Characteristics.
Eiermann B; Rodrigues D; Cohen P; Gustafsson LL
Review: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2021;128(4):557-567
ADR databases for on-site clinical use: Potentials of summary of products characteristics
Eiermann B; Rodriguez D; Cohen P; Gustafsson LL
Other: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2020;108(6):1127-1128
Tribute to Folke Sjoqvist, a Pioneer in Clinical Pharmacology
Dahl M-L; Bergman U; Bertilsson L; Eliasson E; Gustafsson LL; Panagiotidis G; Rane A
Letter: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2020;76(10):1477-1478
Professor Folke Sjoqvist peacefully passed away on March 30, 2020
Bottiger Y; Marquet P; Gustafsson LL
Review: BMJ OPEN. 2017;7(4):e014345
High adherence to the 'Wise List' treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines
Eriksen J; Gustafsson LL; Ateva K; Bastholm-Rahmner P; Ovesjo M-L; Jirlow M; Juhasz-Haverinen M; Larfars G; Malmstrom RE; Wettermark B; Andersen-Karlsson E
Review: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2017;120(1):5-13
Concentration-Response Relationship of Hearing Impairment Caused by Quinine and Salicylate: Pharmacological Similarities but Different Molecular Mechanisms
Alvan G; Berninger E; Gustafsson LL; Karlsson KK; Paintaud G; Wakelkamp M
Corrigendum: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2016;119(5):520
Corrigendum.
Review: INFECTION, GENETICS AND EVOLUTION. 2016;37:192-207
Pharmacogenetics of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in resource-limited settings: Influence on antiretroviral therapy response and concomitant anti-tubercular, antimalarial and contraceptive treatments
Russo G; Paganotti GM; Soeria-Atmadja S; Haverkamp M; Ramogola-Masire D; Vullo V; Gustafsson LL
Editorial comment: GLOBAL HEALTH ACTION. 2015;8:27381
Healing the health system after civil unrest.
Somali-Swedish Action Group for Health Research an
Review: LAKARTIDNINGEN. 2014;111(43):1906-1910
[Clinical decision support can provide assistance in complex health care].
Lövström R; Hoffmann M; Gustafsson LL
Review: FRONTIERS IN PHARMACOLOGY. 2014;5:106
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
Godman B; Wettermark B; van Woerkom M; Fraeyman J; Alvarez-Madrazo S; Berg C; Bishop I; Bucsics A; Campbell S; Finlayson AE; Fuerst J; Garuoliene K; Herholz H; Kalaba M; Laius O; Piessnegger J; Sermet C; Schwabe U; Vlahovic-Palcevski VV; Markovic-Pekovic V; Voncina L; Malinowska K; Zara C; Gustafsson LL
Review: FRONTIERS IN PHARMACOLOGY. 2014;5:109
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs
Godman B; Malmstrom RE; Diogene E; Jayathissa S; McTaggart S; Cars T; Alvarez-Madrazo S; Baumgaertel C; Brzezinska A; Bucsics A; Campbell S; Eriksson I; Finlayson A; Fuerst J; Garuoliene K; Gutierrez-Ibarluzea I; Hviding K; Herholz H; Joppi R; Kalaba M; Laius O; Malinowska K; Pedersen HB; Markovic-Pekovic V; Piessnegger J; Selke G; Sermet C; Spillane S; Tomek D; Voncina L; Vlahovic-Palcevski V; Wale J; Wladysiuk M; van Woerkom M; Zara C; Gustafsson LL
Review: BMC MEDICINE. 2013;11:179
Personalizing health care: feasibility and future implications
Godman B; Finlayson AE; Cheema PK; Zebedin-Brandl E; Gutierrez-Ibarluzea I; Jones J; Malmstrom RE; Asola E; Baumgartel C; Bennie M; Bishop I; Bucsics A; Campbell S; Diogene E; Ferrario A; Fuerst J; Garuoliene K; Gomes M; Harris K; Haycox A; Herholz H; Hviding K; Jan S; Kalaba M; Kvalheim C; Laius O; Loeoev S-A; Malinowska K; Martin A; McCullagh L; Nilsson F; Paterson K; Schwabe U; Selke G; Sermet C; Simoens S; Tomek D; Vlahovic-Palcevski V; Voncina L; Wladysiuk M; van Woerkom M; Wong-Rieger D; Zara C; Ali R; Gustafsson LL
Review: DRUGS. 2013;73(6):533-543
Cytochrome P450-Mediated Changes in Oxycodone Pharmacokinetics/Pharmacodynamics and Their Clinical Implications
Lofdal KCS; Andersson ML; Gustafsson LL
Letter: APPLIED HEALTH ECONOMICS AND HEALTH POLICY. 2013;11(1):79-82
A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing.
Godman B; Gustafsson LL
Editorial comment: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2012;73(1):12-15
e-SPC - delivering drug information in the 21st century: developing new approaches to deliver drug information to prescribers
Maxwell S; Eichler H-G; Bucsics A; Haefeli WE; Gustafsson LL
Corrigendum: CLINICAL PHARMACOKINETICS. 2011;50(9):624
HIV/AIDS patients display lower relative bioavailability of efavirenz than healthy subjects (vol 50, pg 531, 2011)
Mukonzo JK; Nanzigu S; Rekic D; Waako P; Roeshammar D; Ashton M; Ogwal-Okeng J; Gustafsson LL; Aklillu E
Review: EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH. 2010;10(6):707-722
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications
Godman B; Shrank W; Andersen M; Berg C; Bishop I; Burkhardt T; Garuoliene K; Herholz H; Joppi R; Kalaba M; Laius O; McGinn D; Samaluk V; Sermet C; Schwabe U; Teixeira I; Tilson L; Tulunay FC; Vlahovic-Palcevski V; Wendykowska K; Wettermark B; Zara C; Gustafsson LL
Review: PHARMACEUTICALS. 2010;3(8):2470-2494
Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
Godman B; Shrank W; Wettermark B; Andersen M; Bishop I; Burkhardt T; Garuolienè K; Kalaba M; Laius O; Joppi R; Sermet C; Schwabe U; Teixeira I; Tulunay FC; Wendykowska K; Zara C; Gustafsson LL
Review: EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH. 2009;9(1):65-83
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.
Godman B; Wettermark B; Hoffmann M; Andersson K; Haycox A; Gustafsson LL
Other: LAKARTIDNINGEN. 2009;106(1-2):52
[Rational introduction to new drugs requires both a health care and a community perspective].
Gustafsson LL; Wettermark B; Kalin M; Korkmaz S; Persson ME; Almkvist H; Hjemdahl P; Julander M; Kristianson K; Ringertz B; Bergendahl GT; Wiking N
Editorial comment: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2008;64(12):1137-1138
Enhancing the rational use of new medicines across European health care systems
Garattini S; Bertele V; Godman B; Haycox A; Wettermark B; Gustafsson LL
Editorial comment: PHARMACOECONOMICS (AUCKLAND). 2008;26(7):537-550
Recent national and regional drug reforms in Sweden - Implications for pharmaceutical companies in Europe
Wettermark B; Godman B; Andersson K; Gustafsson LL; Haycox A; Bertele V
Letter: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2007;16(10):1177-1179
Access to up-to-date drug information in developing countries continues to pose problems: the case of Uganda
Tumwkirize WA; Ogwal-Okeng JW; Vernby A; Anokbonggo WW; Gustafsson LL; Lundborg CS
Meeting abstract: INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY. 2006;21(4):A33
CYP3A4 and 3A5 catalysed alprazolam metabolism in vitro and in vivo
Miura J; Aklillu E; Allqvist A; Gustafsson LL; Jande M; Mirghani RA; Sayi J; Wennerholm A; Widen J; Bertilsson L
Review: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2005;338(1):299-305
Phenotype-genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles
Rodríguez-Antona C; Sayi JG; Gustafsson LL; Bertilsson L; Ingelman-Sundberg M
Review: LAKARTIDNINGEN. 2003;100(15):1333-1337
[Computerized decision support in drug prescribing I: Better survey of patients' medications yields better quality of care].
Gustafsson LL; Widäng K; Hoffmann M; Andersén-Karlsson E; Elfman K; Johansson B; Johansson E; Larson M
Corrigendum: PHARMACOGENETICS AND GENOMICS. 2001;11(8):743
Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity (vol 11, pg 417, 2001)
Wennerholm A; Johansson I; Hidestrand M; Bertilsson L; Gustafsson LL; IngelmanSundberg M
Review: LAKARTIDNINGEN. 1998;95(24):2824-2828
[Pharmacological pain analysis as diagnostic and therapeutic help].
Arnér S; Gustafsson L; Hansson P; Kinnman E; Sollevi A; Sörensen J
Published conference paper: ANESTHESIOLOGY. 1997;87(6):1309-1317
Systemic absorption and block after epidural injection of ropivacaine in healthy volunteers
Emanuelsson BMK; Persson J; Alm C; Heller A; Gustafsson LL
Published conference paper: JOURNAL OF CHROMATOGRAPHY A. 1997;777(1):73-79
Liquid chromatography tandem mass spectrometry applied to a study of the metabolism of pentamidine - Discussion of possibilities and problems
Nordin J; Wikstrom I; Bronner U; Gustafsson LL; Ericsson O
Other: PAIN. 1995;60(2):217-222
BENEFICIAL-EFFECTS OF KETAMINE IN A CHRONIC PAIN STATE WITH ALLODYNIA, POSSIBLY DUE TO CENTRAL SENSITIZATION
PERSSON J; AXELSSON G; HALLIN RG; GUSTAFSSON LL
Visa fler

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI